Literature DB >> 24806602

Prediction of survival and cancer recurrence using metabolic volumetric parameters measured by 18F-FDG PET/CT in patients with surgically resected rectal cancer.

Hong Jae Jo1, Seong-Jang Kim, Hyo Young Lee, In Joo Kim.   

Abstract

OBJECTIVE: The goal of the present study was to determine whether the volumetric parameters such as metabolic tumor volume (MTV) and total lesion glycolysis (TLG) measured by F-FDG PET/CT could be used as prognostic factors for the recurrence-free survival (RFS) and overall survival (OS) in patients with surgically resected rectal cancer. PATIENTS AND METHODS: A retrospective review identified 73 patients with surgically resected rectal cancer who received F-FDG PET/CT. Survival analysis was conducted using Kaplan-Meier analysis, and survival curves stratified by age, sex, lymph node status, surgical resection margin, American Joint Committee on Cancer (AJCC) stage, and volumetric parameters of F-FDG PET/CT were generated for the estimation of OS and RFS. Independent predictive factors for survival were determined using Cox proportional hazards model.
RESULTS: High MTV, high TLG, advanced AJCC stage, lymph node (+), and surgical margin (+) group showed shorter OS in rectal cancer patients. Cox proportional hazards regression analysis showed that only surgical margin (+) was associated with poor OS. The early AJCC stage, lower MTV, and lower TLG were associated with better RFS in the current study. Cox proportional hazards regression analysis reveals that the surgical margin (+) was the potent predictor of OS. However, none of the factors was associated with RFS.
CONCLUSIONS: In conclusion, the results of this study suggest that volumetric parameters of F-FDG PET/CT could be significant prognostic factors in surgically resected rectal cancer.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24806602     DOI: 10.1097/RLU.0000000000000438

Source DB:  PubMed          Journal:  Clin Nucl Med        ISSN: 0363-9762            Impact factor:   7.794


  8 in total

1.  Radiation dose intensification in pre-operative chemo-radiotherapy for locally advanced rectal cancer.

Authors:  F Alongi; S Fersino; R Mazzola; A Fiorentino; N Giaj-Levra; F Ricchetti; R Ruggieri; G Di Paola; M Cirillo; S Gori; M Salgarello; G Zamboni; G Ruffo
Journal:  Clin Transl Oncol       Date:  2016-06-07       Impact factor: 3.405

2.  A pilot study for texture analysis of 18F-FDG and 18F-FLT-PET/CT to predict tumor recurrence of patients with colorectal cancer who received surgery.

Authors:  Masatoyo Nakajo; Yoriko Kajiya; Atsushi Tani; Megumi Jinguji; Masayuki Nakajo; Masaki Kitazono; Takashi Yoshiura
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-08-03       Impact factor: 9.236

3.  Value of Primary Rectal Tumor PET/MRI in the Prediction of Synchronic Metastatic Disease.

Authors:  Marcelo A Queiroz; Cinthia D Ortega; Felipe R Ferreira; Fernanda C Capareli; Sergio C Nahas; Giovanni G Cerri; Carlos A Buchpiguel
Journal:  Mol Imaging Biol       Date:  2021-11-09       Impact factor: 3.488

4.  Value of CT, FDG PET-CT and serum tumor markers in staging recurrent colorectal cancer.

Authors:  Meltem Caglar; Can Yener; Erdem Karabulut
Journal:  Int J Comput Assist Radiol Surg       Date:  2014-09-12       Impact factor: 2.924

5.  Predictive Value of [18F]FDG PET/CT for Lymph Node Metastasis in Rectal Cancer.

Authors:  Sung Hoon Kim; Bong-Il Song; Beong Woo Kim; Hae Won Kim; Kyoung Sook Won; Sung Uk Bae; Woon Kyung Jeong; Seong Kyu Baek
Journal:  Sci Rep       Date:  2019-03-21       Impact factor: 4.379

6.  Prognostic Value of Intratumor Metabolic Heterogeneity Parameters on 18F-FDG PET/CT for Patients with Colorectal Cancer.

Authors:  Xin Liu; Kun Xiang; Guang-Yong Geng; Shi-Cun Wang; Ming Ni; Yi-Fan Zhang; Hai-Feng Pan; Wei-Fu Lv
Journal:  Contrast Media Mol Imaging       Date:  2022-01-30       Impact factor: 3.161

7.  Prognostic Impact of Total Lesion Glycolysis (TLG) from Preoperative 18F-FDG PET/CT in Stage II/III Colorectal Adenocarcinoma: Extending the Value of PET/CT for Resectable Disease.

Authors:  Sea-Won Lee; Hye Lim Park; Nara Yoon; Ji Hoon Kim; Jin Kyoung Oh; Jae Ho Buyn; Eun Kyoung Choi; Ji Hyung Hong
Journal:  Cancers (Basel)       Date:  2022-01-24       Impact factor: 6.639

8.  Prognostic value of metabolic parameters on 18F-fluorodeoxyglucose positron tomography/computed tomography in classical rectal adenocarcinoma.

Authors:  Byung Wook Choi; Sungmin Kang; Sung Uk Bae; Woon Kyung Jeong; Seong Kyu Baek; Bong-Il Song; Kyoung Sook Won; Hae Won Kim
Journal:  Sci Rep       Date:  2021-06-21       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.